Related Experiment Videos
Muscarinic thioligands with cyclopentane nucleus
A Piergentili1, M Pigini, W Quaglia
1Dipartimento di Scienze Chimiche, Università di Camerino, Italy.
Bioorganic & Medicinal Chemistry
|December 1, 1996
Summary
Researchers explored deoxamuscarine derivatives as muscarinic agonists. Modifications to the ammonium group reduced potency, while specific substitutions on the cyclopentane ring influenced subtype selectivity for M2 and M3 receptors.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Discovery
Background:
- Deoxamuscarine derivatives are investigated for their potential as muscarinic agonists.
- Understanding structure-activity relationships is crucial for designing selective muscarinic receptor ligands.
Purpose of the Study:
- To synthesize and evaluate thio- and benzoyl-derivatives of deoxamuscarine as muscarinic agonists.
- To determine the impact of structural modifications on muscarinic receptor binding and functional activity.
- To assess subtype selectivity for M2 and M3 muscarinic receptors.
Main Methods:
- Radioligand binding assays were employed to measure binding affinity.
- Functional tests were conducted to assess agonist activity.
- Structure-activity relationships were analyzed by comparing derivatives to deoxamuscarine.
Main Results:
- Lipophilic pocket recognition requires precise structural dimensions, with minimal tolerance for modifications.
- Substitution of the ammonium group with a sulphonium group significantly reduced muscarinic potency.
- The muscarinic sub-site accommodates bulky functions when linked via an oxygen bridge to a cyclopentane carrier.
- Esterification of the oxygen-linked moiety enhanced M2 subtype selectivity.
- Etherification of the oxygen-linked moiety increased M3 subtype selectivity.
Conclusions:
- Structural modifications of deoxamuscarine significantly impact muscarinic receptor interaction and subtype selectivity.
- Specific functionalization strategies can yield selective M2 or M3 muscarinic receptor agonists.
- These findings provide insights for the rational design of novel muscarinic receptor modulators.